Cargando…
Integrating stereotactic radiotherapy and systemic therapies
This paper focuses on stereotactic radiotherapy (SRT ) interactions with targeted therapies and immune system modulating agents because SRT inevitably interacts with them in the treatment of oligometastatic patients. Radiation oncologists need to be aware of the advantages and risks of these interac...
Autores principales: | Palumbo, Isabella, Pasqualetti, Francesco, Delishaj, Durim, Gonnelli, Alessandra, Aristei, Cynthia, Borghesi, Simona, Pirtoli, Luigi, Belgioia, Liliana, Arcangeli, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Via Medica
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9591045/ https://www.ncbi.nlm.nih.gov/pubmed/36299395 http://dx.doi.org/10.5603/RPOR.a2022.0020 |
Ejemplares similares
-
Doses, fractionations, constraints for stereotactic radiotherapy
por: Borghesi, Simona, et al.
Publicado: (2022) -
Stereotactic radiotherapy for oligometastases in the lymph nodes
por: Pasqualetti, Francesco, et al.
Publicado: (2022) -
Stereotactic radiotherapy for liver oligometastases
por: Menichelli, Claudia, et al.
Publicado: (2022) -
Radiobiology of stereotactic radiotherapy
por: Mangoni, Monica, et al.
Publicado: (2022) -
Stereotactic radiotherapy for adrenal oligometastases
por: Borghesi, Simona, et al.
Publicado: (2022)